news highlights released today...https://stockhouse.com/news/press-releases/2020/09/15/xortx-highlights-new-studies-of-acute-kidney-disease-due-to-covid-19-infection
all positive it seems, ready to rock, good luck.
-------------------------
Dr. Allen Davidoff, CEO of XORTX stated, “For the 1 in 5 individuals who are hospitalized due to COVID-19 infection, the pattern of AKI is concerning. This includes a substantial number of patients who have long-term kidney injury and those who will remain on dialysis for the remainder of their lives. We strongly believe that xanthine oxidase inhibition with our XRx-101 program can attenuate the progression and severity of injury for many hospitalized COVID-19 patients.”
------------------------
In other news, the Company announces that it has retained Lakeshore Securities Inc. (“Lakeshore Securities”) to provide market making services to the Company in compliance with the policies and guidelines of the CSE and other applicable legislation. Lakeshore Securities will trade shares of XORTX on the CSE with the objective of maintaining a reasonable market and improving the liquidity of XORTX common shares. There are no performance factors contained in the agreement and Lakeshore Securities will not receive shares or options as compensation. Lakeshore Securities and the Company are unrelated and unaffiliated entities, but Lakeshore Securities and/or its clients may have an interest, directly or indirectly, in the securities of the Company.